Pregled bibliografske jedinice broj: 1247357
Ocular Manifestations of Miller Fisher Syndrome: a Case Report
Ocular Manifestations of Miller Fisher Syndrome: a Case Report // Medical Archives, 75 (2021), 3; 234-236 doi:10.5455/medarh.2021.75.234-236 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1247357 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Ocular Manifestations of Miller Fisher Syndrome: a
Case Report
Autori
Ravlic, Maja ; Knezevic, Lana ; Krolo, Iva ; Herman, Jelena
Izvornik
Medical Archives (0350-199X) 75
(2021), 3;
234-236
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Miller Fisher syndrome, ophthalmoplegia, antiganglioside antibody, diplopia, ptosis
Sažetak
Miller Fisher syndrome (MFS) is a variant of Guillain-Barré syndrome and is characterised by a clinical triad of ophthalmoplegia, ataxia and areflexia. Objectives: This report presents an atypical case of MFS characterized by ocular and gastrointestinal involvement, and anti-ganglioside antibody- positivity. Methods: A 17-year old boy was referred to our ophthalmology emergency room with signs and symptoms of diplopia and upper lid ptosis of the right eye. He underwent a complete ophthalmologic examination with special reference to strabologic status, as well as a neuropediatric examination with serum antiganglioside antibody panel. Results: Strabologic examination showed horisontal diplopia (near and far), ptosis of the upper eyelid on the right and bilateral ophthalmoplegia (limited elevation). Orthoptic examination revealed esotropia of 8 prism dioptres (PD) at near and 18 PD at far distance. A pediatric neurologist found normal limb power, deep tendon reflexes and flexor plantar responses, but attenuated right patellar reflex. Serum anti-GQ1b IgG (+++), anti-GQ1b IgM (++) and anti- GD1a IgM(++) were positive. Positivity of anti-GQ1b IgG antibody confirmed the existence of incomplete MFS. We treated the patient with systemic intravenous immunoglobulins for five days, and after five months of follow-up, all symptoms resolved. C
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE